Skip to content 
If you’re considering stem cell or PRP therapy for chronic knee or joint pain, here’s what actually works and what doesn’t. These treatments address tissue damage directly rather than masking symptoms, but they’re not right for every patient or every condition. Understanding the difference before you commit protects both your time and your health.
Key Takeaways
- PRP and stem cell therapy are distinct treatments with different mechanisms, and using the wrong one for your condition produces poor results
- Cellular therapy works by triggering biological repair at the tissue level, not by suppressing pain signals the way medications do
- The window where regenerative treatments work best is earlier than most patients think, meaning delay carries a real cost
- Not every patient is a candidate, and a proper clinical evaluation is what determines fit before any treatment begins
- Dr. Fawad Mian leads Ascend Regenerative’s non-surgical approach from its Denville, NJ practice, serving patients throughout Morris County
Why Does Medication Keep Failing People With Chronic Joint Pain?
Because medication was never designed to repair what’s actually broken.
Anti-inflammatories and cortisone injections work on the inflammatory cascade. They interrupt the pain signal. What they don’t do is rebuild cartilage, restore a degenerating tendon attachment, or reverse the structural damage that’s been accumulating in your joint for years.
Pain medication is a volume dial on the signal, not a repair mechanism for the source.
This is why so many people in their 40s and 50s cycle through treatment after treatment without resolution. The tissue damage is real, it’s ongoing, and no medication addresses it directly. Repeated cortisone injections may reduce inflammation in the short term, but the underlying degeneration continues. At a certain point, the treatments intended to help stop working precisely because the problem they were designed to manage keeps progressing.
That’s the trap. Cellular therapy represents a different category of solution, not a better version of what you’ve already tried.
What Actually Happens Inside a Joint During PRP Therapy?
Platelets carry proteins called growth factors, including PDGF, TGF-beta, and VEGF, that signal the body to begin tissue repair. In a normal injury with good blood supply, those signals arrive in sufficient concentration to drive healing. In cartilage and tendons, the blood supply is poor. The repair signals don’t arrive at the required concentration, which is why chronic injuries remain chronic.
PRP therapy addresses this directly. A concentrated preparation of your own platelets is drawn from your blood, processed, and injected at the precise site of tissue damage. The result is a high-density delivery of repair signals to a location that can’t receive them through normal circulation.
The treatment isn’t suppressing the problem. It’s attempting to solve it at the tissue level. That’s a fundamental difference from anything in the conventional treatment toolkit.
How Is Stem Cell Therapy Different, and When Does It Matter?
PRP works by amplifying the repair signals sent to cells that are already present in the tissue. Stem cell therapy is relevant when the tissue has lost too much of its own cellular capacity to respond to growth factor stimulation alone.
Think of it this way: PRP is a strong signal to existing cells to do more work. Stem cell therapy introduces new cellular material when the existing cells aren’t sufficient for meaningful repair.
Consider a typical case. A patient with moderate knee osteoarthritis and damaged but intact cartilage is often a good candidate for PRP. A patient with more advanced degeneration, a longer history of failed treatments, or significant cartilage loss may respond better to a stem cell-based protocol because the biological foundation for PRP to work with has eroded.
At our Morris County practice, patients with more advanced joint degeneration typically respond better to stem cell protocols, while those with early-to-moderate tissue damage and a shorter treatment history tend to see strong results from PRP. Getting that distinction right before treatment begins is the difference between a protocol that works and one that doesn’t.
The reason so many people conclude “regenerative medicine didn’t work for me” is often that they received the wrong protocol for their specific tissue state, not that the treatments themselves failed.
Dr. Fawad Mian, a neurologist with specialized expertise in the body’s healing mechanisms, built Ascend Regenerative’s evaluation process around that distinction specifically.
Who Is This NOT Right For?
This matters, and it’s worth being direct about it.
Cellular therapy is not appropriate for patients with active cancer or those currently undergoing chemotherapy, because the growth factors involved in regenerative treatment can interfere with oncological care. It’s also not appropriate for patients with active systemic infections, or as a first response to an acute injury that hasn’t been properly evaluated yet.
Patients on certain blood thinners need a clinical review before proceeding, as their medication can affect both the procedure and the healing response. Even patients with advanced joint degeneration, including significant cartilage loss or bone-on-bone conditions, may still respond well to stem cell or cellular treatments. The key is a thorough evaluation of the individual patient, their joint health, medical history, and previous treatments to determine the regenerative approach most appropriate for their specific condition.
The goal is to match the right treatment to the right patient. That’s what makes the evaluation worth doing before any commitment is made.
Acting Now vs. Waiting: What You’re Actually Choosing Between
| Decision | What Happens to Your Joint | Pain Trajectory | Future Treatment Options |
| Pursue evaluation and appropriate cellular therapy now | Tissue repair is initiated while a viable structure remains | Gradual improvement in function and daily pain | Maximum, with early intervention, preserving more options |
| Continue managing with medication | Degeneration continues unaddressed | Stable at best, worsening as tissue loss compounds | Narrowing, as structural damage accumulates |
| Wait and see | Same biological progression as above | No improvement, potential worsening | Fewer options, the longer degeneration advances |
| Rely on repeated cortisone alone | Potential for accelerated cartilage breakdown over time | Short-term relief cycles with diminishing returns | May compromise tissue quality for future interventions |
Waiting feels like a neutral choice. It isn’t.
Joint degeneration is a progressive process. Every month of delay is a month of additional structural loss, and regenerative treatments work best when there’s still enough viable tissue to repair. Inaction has a cost. It just doesn’t present that cost until the options have narrowed significantly.
What Results Are Realistic and How Long Does It Take?
This isn’t a quick fix, and anyone who tells you otherwise is selling something.
PRP therapy triggers a biological repair process that follows the body’s own timeline. A typical pattern looks like this: mild soreness in the first one to two weeks as the inflammatory repair response activates, followed by a gradual reduction in pain with activity through weeks four to six, with measurable functional improvement clearer around the three-month mark.
Stem cell protocols generally require a longer observation window before the full extent of improvement becomes clear.
The patients who get the most from these treatments are those who go in with realistic expectations. The goal is a meaningful, durable improvement in quality of life. Not zero pain overnight. Better function, less reliance on medication, more of your life back. Real improvement, delivered on a biological timeline.
Frequently Asked Questions
How do I know if my pain is the kind that cellular therapy can actually help?
The most reliable answer comes from a clinical evaluation that includes imaging and a thorough review of your treatment history. Generally, cellular therapy works best for musculoskeletal pain caused by tissue damage where viable structure remains, including tendon injuries, partial cartilage loss, and joint degeneration. If you’ve been managing pain with medication for years without resolution, that’s a strong signal the structural cause hasn’t been addressed.
Is PRP the same as stem cell therapy?
They’re different treatments with different mechanisms. PRP delivers concentrated growth factors from your own blood to stimulate repair in existing tissue. Stem cell therapy introduces cells capable of generating new tissue in areas where the existing cellular population is insufficient to drive meaningful repair on its own. A proper evaluation determines which is appropriate for your condition.
How many treatments will I need before I see results?
It depends on the condition and the protocol selected. PRP is often administered as a series of one to three injections, with most patients noticing changes in the four-to-eight-week range. Stem cell protocols vary more widely. There’s no universal answer, which is why the evaluation process matters more than any general estimate.
Will this work if cortisone injections have already failed?
Prior cortisone use doesn’t disqualify you, but it’s a relevant clinical history. Repeated cortisone injections can affect tissue quality, and a thorough evaluation accounts for that. Many patients who didn’t respond to cortisone respond to PRP or stem cell approaches because the mechanism is entirely different: you’re not suppressing inflammation, you’re initiating repair.
Is cellular therapy covered by insurance?
Most PRP and stem cell therapies for musculoskeletal pain are not covered by standard insurance and are treated as elective or investigational. That’s a real consideration. The honest framing is that treatment cost needs to be weighed against the ongoing cost of unresolved pain, continued medication dependence, potential surgical intervention, and reduced quality of life compounded over the years. Inaction carries its own price.
What makes Ascend Regenerative different from a standard orthopedic practice?
Ascend Regenerative specializes in regenerative medicine as a primary focus, not as an add-on to a surgical practice. Dr. Fawad Mian is a neurologist with deep expertise in the body’s healing mechanisms who has built the practice around non-surgical treatment pathways. The evaluation process is designed to identify the right regenerative protocol for each patient’s specific tissue state, including telling patients honestly when cellular therapy isn’t the right answer for their situation.
What should I bring to my first consultation?
Bring any imaging you have, including X-rays and MRI reports, a summary of treatments you’ve already tried, and your current medication list. The more specific you can be about when the pain started, what makes it better or worse, and what hasn’t worked, the more productive the initial conversation will be. You’re not starting from scratch. You’re building on what’s failed to find what won’t.
If you’ve been living with chronic joint or musculoskeletal pain and you’re ready to stop managing symptoms and start addressing the actual structural cause, the next step is a consultation at Ascend Regenerative in Denville, NJ. The evaluation is designed to tell you clearly whether you’re a candidate and what a realistic treatment path looks like for your specific situation. Dr. Fawad Mian brings neurology-grounded expertise in the body’s healing mechanisms to every evaluation, and that foundation shapes how treatment decisions get made.
The window where regenerative medicine works best doesn’t stay open indefinitely. If you’ve been waiting to find out whether this is right for you, now is the time to get that answer.
About Ascend Regenerative:
Ascend Regenerative is a regenerative medicine practice based in Denville, NJ, led by Dr. Fawad Mian, a neurologist specializing in non-surgical treatments for chronic pain. The practice serves patients throughout Morris County with personalized treatment plans including PRP therapy, stem cell therapy, and targeted pain injections, focused on addressing the structural causes of pain rather than the symptoms alone.
